Current assets decreased 35.1%
Current assets changed -35.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$367.5M→$238.5M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →VNDA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets decreased 36.4%
Total assets changed -36.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$601.1M→$382.3M4 prior comparisons
Working capital decreased 66.6%
Working capital changed -66.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$249.6M→$83.5M4 prior comparisons
Current ratio decreased 50.6%
Current ratio changed -50.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
3.12→1.544 prior comparisons
Working capital / assets moved 1969 bp lower
Working capital / assets changed -1969 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
41.53%→21.84%4 prior comparisons
Operating margin moved 2192 bp higher
Operating margin changed +2192 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-55.61%→-33.69%2 prior comparisons
Operating income increased 24.8%
Operating income changed +24.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$31.3M→-$23.5M2 prior comparisons
Revenue increased 24.1%
Revenue changed +24.1% from the comparable as-filed period.
$56.3M→$69.8M2 prior comparisons
Current liabilities increased 31.5%
Current liabilities changed +31.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$117.9M→$155.0M4 prior comparisons
Shares outstanding increased 2.3%
Shares outstanding changed +2.3% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
59,096,630→60,469,6878 prior comparisons
Free-cash-flow proxy increased 9.6%
Free-cash-flow proxy changed +9.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$31.8M→-$28.7M2 prior comparisons
Operating cash flow increased 10.1%
Operating cash flow changed +10.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$31.6M→-$28.4M2 prior comparisons
Free-cash-flow margin moved 1533 bp higher
Free-cash-flow margin changed +1533 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-56.50%→-41.17%2 prior comparisons
Operating cash-flow margin moved 1549 bp higher
Operating cash-flow margin changed +1549 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-56.22%→-40.73%2 prior comparisons
Receivables / revenue moved 344 bp lower
Receivables / revenue changed -344 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
89.84%→86.39%2 prior comparisons
Research & development increased 22.4%
Research & development changed +22.4% from the comparable as-filed period.
$22.6M→$27.6M2 prior comparisons
Trade receivables increased 19.3%
Trade receivables changed +19.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$50.5M→$60.3M4 prior comparisons
Capital expenditure increased 93.2%
Capital expenditure changed +93.2% from the comparable as-filed period.
$161,000→$311,0002 prior comparisons
Cash & equivalents decreased 11.6%
Cash & equivalents changed -11.6% from the comparable as-filed period.
$70.0M→$61.9M3 prior comparisons
Inventory decreased 25.2%
Inventory changed -25.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.0M→$1.5M4 prior comparisons
Inventory / revenue moved 144 bp lower
Inventory / revenue changed -144 basis points from the comparable as-filed period.
3.63%→2.19%2 prior comparisons
Capex / revenue moved 16 bp higher
Capex / revenue changed +16 basis points from the comparable as-filed period.
0.29%→0.45%2 prior comparisons
Stock-based compensation increased 10.7%
Stock-based compensation changed +10.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.1M→$2.3M2 prior comparisons
SBC / revenue moved 40 bp lower
SBC / revenue changed -40 basis points from the comparable as-filed period.
3.75%→3.35%2 prior comparisons
Selling, general & administrative decreased 1.2%
Selling, general & administrative changed -1.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$60.3M→$59.6M2 prior comparisons
R&D / revenue moved 54 bp lower
R&D / revenue changed -54 basis points from the comparable as-filed period.
40.11%→39.56%2 prior comparisons
Current assets decreased 33.0%
Current assets changed -33.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$394.9M→$264.5M4 prior comparisons
Total assets decreased 34.0%
Total assets changed -34.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$624.7M→$412.5M4 prior comparisons
Working capital decreased 63.3%
Working capital changed -63.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$273.4M→$100.5M4 prior comparisons
Current ratio decreased 50.4%
Current ratio changed -50.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
3.25→1.614 prior comparisons
Working capital / assets moved 1941 bp lower
Working capital / assets changed -1941 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
43.77%→24.36%4 prior comparisons
Free-cash-flow proxy decreased 101.0%
Free-cash-flow proxy changed -101.0% from the comparable as-filed period.
-$15.6M→-$31.3M3 prior comparisons
Operating income decreased 65.7%
Operating income changed -65.7% from the comparable as-filed period.
-$38.5M→-$63.8M2 prior comparisons
Operating cash flow decreased 103.7%
Operating cash flow changed -103.7% from the comparable as-filed period.
-$15.3M→-$31.1M3 prior comparisons
Current liabilities increased 35.0%
Current liabilities changed +35.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$121.5M→$164.0M4 prior comparisons
Operating margin moved 5307 bp lower
Operating margin changed -5307 basis points from the comparable as-filed period.
-73.21%→-126.28%2 prior comparisons
Cash & equivalents decreased 31.0%
Cash & equivalents changed -31.0% from the comparable as-filed period.
$81.0M→$55.9M3 prior comparisons
Research & development increased 68.0%
Research & development changed +68.0% from the comparable as-filed period.
$22.0M→$37.0M2 prior comparisons
Shares outstanding increased 2.3%
Shares outstanding changed +2.3% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
59,089,130→60,462,6878 prior comparisons
Trade receivables increased 32.7%
Trade receivables changed +32.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$45.0M→$59.7M4 prior comparisons
Free-cash-flow margin moved 3230 bp lower
Free-cash-flow margin changed -3230 basis points from the comparable as-filed period.
-29.57%→-61.87%2 prior comparisons
Operating cash-flow margin moved 3249 bp lower
Operating cash-flow margin changed -3249 basis points from the comparable as-filed period.
-29.00%→-61.49%2 prior comparisons
Receivables / revenue moved 3258 bp higher
Receivables / revenue changed +3258 basis points from the comparable as-filed period.
85.55%→118.13%2 prior comparisons
Revenue decreased 3.9%
Revenue changed -3.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$52.6M→$50.5M2 prior comparisons
Capital expenditure decreased 36.5%
Capital expenditure changed -36.5% from the comparable as-filed period.
$299,000→$190,0003 prior comparisons
R&D / revenue moved 3132 bp higher
R&D / revenue changed +3132 basis points from the comparable as-filed period.
41.81%→73.13%2 prior comparisons
Selling, general & administrative increased 11.2%
Selling, general & administrative changed +11.2% from the comparable as-filed period.
$64.6M→$71.8M2 prior comparisons
Inventory decreased 22.6%
Inventory changed -22.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.2M→$1.7M4 prior comparisons
Capex / revenue moved 19 bp lower
Capex / revenue changed -19 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.57%→0.38%2 prior comparisons
Inventory / revenue moved 80 bp lower
Inventory / revenue changed -80 basis points from the comparable as-filed period.
4.12%→3.32%2 prior comparisons
SBC / revenue moved 17 bp higher
SBC / revenue changed +17 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.00%→4.17%2 prior comparisons
Stock-based compensation increased 0.0%
Stock-based compensation changed +0.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.1M→$2.1M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.